New skin disease drug enters first human trials
NCT ID NCT07412691
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 6 times
Summary
This study tests a new drug called BG-A3004 for the first time in humans. It aims to check the drug's safety and how the body processes it in healthy volunteers and people with immune-related skin diseases. The study is split into two parts: single dose in healthy people and multiple doses in patients. Results will help decide if further testing is warranted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Beijing Tongren Hospital, Cmu
RECRUITINGBeijing, Beijing Municipality, 100010, China
-
Hangzhou First Peoples Hospital
RECRUITINGHangzhou, Zhejiang, 310006, China
-
Huashan Hospital Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200040, China
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100034, China
-
Suzhou Municipal Hospital
RECRUITINGSuzhou, Jiangsu, 215002, China
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, Chongqing Municipality, 630014, China
-
The First Affiliated Hospital of Fujian Medical University
RECRUITINGFuzhou, Fujian, 350005, China
-
The First Affiliated Hospital of Wenzhou Medical University
RECRUITINGWenzhou, Zhejiang, 325000, China
-
The First Hospital of China Medical University
RECRUITINGShenyang, Liaoning, 110001, China
-
The Second Hospital of Hebei Medical University
RECRUITINGShijiazhuang, Hebei, 050000, China
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, 410008, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could your daily commute be drying out your skin?
- Can a new pill help teens regrow hair lost to alopecia?
- Can allergy and glaucoma drugs regrow hair when delivered by microneedling?
- Can a daily pill bring back hair in severe alopecia?
- Can Real-World data unlock better skin disease care?
- Can a daily pill regrow hair in alopecia areata? a trial seeks answers